Ifp Advisors, Inc Durect Corp Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.38 - $0.64 $5,700 - $9,600	15,000 New	15,000 $30,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.64 $5,700 - $9,600	-15,000 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.6 - $2.02 $6,400 - $8,080	4,000 Added 36.36%	15,000 $24,000
Q1 2021 Apr 30, 2021	BUY	$1.86 - $2.87 $1,860 - $2,870	1,000 Added 10.0%	11,000 $22,000
Q1 2020 May 12, 2020	SELL	$0.97 - $2.85 $1,455 - $4,275	-1,500 Reduced 13.04%	10,000 $15,000
Q4 2019 Jan 17, 2020	BUY	$1.69 - $3.8 $4,225 - $9,500	2,500 Added 27.78%	11,500 $37,000
Q3 2019 Nov 07, 2019	BUY	$0.61 - $2.21 $5,490 - $19,890	9,000 New	9,000 $18,000
Q3 2018 Oct 25, 2018	SELL	$1.06 - $1.69 $1,590 - $2,535	-1,500 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$1.56 - $2.51 $2,340 - $3,764	1,500 New	1,500 $0
Q4 2017 Jan 24, 2018	SELL	$0.78 - $2.1 $4,680 - $12,600	-6,000 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	6,000	6,000 $7,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.